Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice

被引:644
作者
Farmer, KC [1 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Oklahoma City, OK 73104 USA
关键词
D O I
10.1016/S0149-2918(99)80026-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Researchers and clinicians have used numerous methods in their attempts to adequately assess patient compliance (adherence) with medication regimens and to identify noncompliant patients. Large variations have been reported in the extent of noncompliance in individual patients and large populations. In addition, nonadherence has often been poorly defined. Direct measures of adherence include drug assays of blood or urine, use of drug markers with the target medication, and direct observation of the patient receiving the medication. Indirect measures of adherence imply that the medication has been used by the patient; these measures include various forms of self-reporting by the patient, medication measurement (pill count), use of electronic monitoring devices, and review of prescription records and claims. Compliance measures should be assessed on the basis of their validity (sensitivity and specificity or statistical correlation) and the reference standard used. Many early studies used pill counts as a reference standard, but electronic monitoring devices such as the Medication Event Monitoring System have replaced pill counts as the reference standard. The choice of a method for measuring adherence to a medication regimen should be based on the usefulness and reliability of the method in light of the researcher's or clinician's goals. Specific methods may be more applicable to certain situations, depending on the type of adherence being assessed, the precision required, and the intended application of the results.
引用
收藏
页码:1074 / 1090
页数:17
相关论文
共 61 条
[1]   DISCONTINUATION OF ANTIHYPERLIPIDEMIC DRUGS - DO RATES REPORTED IN CLINICAL-TRIALS REFLECT RATES IN PRIMARY-CARE SETTINGS [J].
ANDRADE, SE ;
WALKER, AM ;
GOTTLIEB, LK ;
HOLLENBERG, NK ;
TESTA, MA ;
SAPERIA, GM ;
PLATT, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (17) :1125-1131
[2]   THE RUN-IN PERIOD IN CLINICAL-TRIALS - THE EFFECT OF MISCLASSIFICATION ON EFFICIENCY [J].
BRITTAIN, E ;
WITTES, J .
CONTROLLED CLINICAL TRIALS, 1990, 11 (05) :327-338
[3]   Adherence to single daily dose of aspirin in a chemoprevention trial - An evaluation of self-report and microelectronic monitoring [J].
Burney, KD ;
Krishnan, K ;
Ruffin, MT ;
Zhang, DW ;
Brenner, DE .
ARCHIVES OF FAMILY MEDICINE, 1996, 5 (05) :297-300
[4]   Assessing compliance to antihypertensive medications using computer-based pharmacy records [J].
Christensen, DB ;
Williams, B ;
Goldberg, HI ;
Martin, DP ;
Engelberg, R ;
LoGerfo, JP .
MEDICAL CARE, 1997, 35 (11) :1164-1170
[5]  
Craghead R M, 1991, Hosp Pharm, V26, P616
[6]   EFFECT OF AUTOMATED PRESCRIPTION TRANSMITTAL ON NUMBER OF UNCLAIMED PRESCRIPTIONS [J].
CRAGHEAD, RM ;
WARTSKI, DM .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1989, 46 (02) :310-312
[7]   ACCURACY OF INDIRECT MEASURES OF MEDICATION COMPLIANCE IN HYPERTENSION [J].
CRAIG, HM .
RESEARCH IN NURSING & HEALTH, 1985, 8 (01) :61-66
[8]  
Cramer J. A., 1991, Patient compliance in medical practice and clinical trials, P123
[9]   COMPLIANCE DECLINES BETWEEN CLINIC VISITS [J].
CRAMER, JA ;
SCHEYER, RD ;
MATTSON, RH .
ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (07) :1509-1510
[10]   HOW OFTEN IS MEDICATION TAKEN AS PRESCRIBED - A NOVEL ASSESSMENT TECHNIQUE [J].
CRAMER, JA ;
MATTSON, RH ;
PREVEY, ML ;
SCHEYER, RD ;
OUELLETTE, VL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (22) :3273-3277